Lenvatinib suppresses cancer stem-like cells in HCC by inhibiting FGFR1-3 signaling, but not FGFR4 signaling

Shigesawa, T; Maehara, O; Suda, G; Natsuizaka, M; Kimura, M; Shimazaki, T; Yamamoto, K; Yamada, R; Kitagataya, T; Nakamura, A; Suzuki, K; Ohara, M; Kawagishi, N; Umemura, M; Nakai, M; Sho, T; Morikawa, K; Ogawa, K; Ohnishi, S; Sugiyama, M; Mizokami, M; Takeda, H; Sakamoto, N

Suda, G (corresponding author), Hokkaido Univ, Dept Gastroenterol & Hepatol, Grad Sch Med, North Ward, North 15 West 5, Sapporo, Hokkaido 0608648, Japan.

CARCINOGENESIS, 2021; 42 (1): 58

Abstract

In hepatocellular carcinoma (HCC), a subset of cells defined by high CD44 and CD133 expression has been reported to possess cancer stem-like cell (CSC......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索